As shown in Fig 2A, PKCλ, MET, NOTCH1, CD133, MYC, ALDH1A3, NOTCH3, OCT4, and CD44 were all enriched in stage III-IV basal-like breast cancers. This evidence concerns the gene MET and breast carcinoma.